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Abstract
Background Facial flap surgery predominantly leads to
good functional results. However, in some cases, it can
cause unsatisfactory esthetic results. They include persis-
tent erythema, pincushioning, and development of hyper-
trophic scars. Conservative, reliable treatment for facial
flaps is lacking. Pressure and silicone therapy have prov-
en to result in significant improvement in scar erythema,
pliability, and thickness in postburn hypertrophic scars.
By combining these therapies in a facial mask, the esthet-
ic outcome of facial flaps could be improved. In this ret-
rospective study, the efficacy of a unique transparent face
mask containing silicone sheets on the esthetic outcome
of postsurgical facial flaps is assessed.
Methods Twenty-one patients were assigned to facial pressure
mask therapy after they underwent facial flap surgery between
July 2012 and September 2015. Patients were treated for a
mean duration of 46 weeks. The effects of pressure mask
therapy were examined by means of the Patient and
Observer Scar Assessment Scale (POSAS).
Results All POSAS components showed a reduction between
start and end of therapy, while itchiness, pigmentation, pliabil-
ity, thickness, and relief of the flap improved significantly
(P < 0.05). Mean total and patient score showed significant
reduction between start and end of therapy.
Conclusions This study shows that a facial pressure mask
layered with silicone results in noticeable flap improvement
with a long-lasting result.
Level of Evidence: Level III, therapeutic study.
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Introduction
Worldwide, the number of people that suffer from skin cancer
is increasing every year. Surgical resection is the standard of
care in facial plastic surgery [1]. One of the standard proce-
dures to close facial defects is local or regional soft tissue flaps
[2].
In order to cover a defect and to restore facial anatomy as well
as possible, many options for surgical flaps exist. Well-known
and commonly used flaps include Abbe, rhomboid, forehead,
bilobed, and glabella flap [3, 4]. All of these flaps are known to
mostly give good esthetic results. However, esthetic outcome
may not be satisfying in all cases. Most adverse effects after
repair of defects in the face by flaps are mild. They include
persistent scar erythema, pincushioning, and development of hy-
pertrophic and widened scars [1, 5–11].
Current therapies for flap revision after unsatisfactory es-
thetic results include photothermolysis, laser resurfacing,
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liposuction, injections with corticosteroids, and surgery [1, 8,
10, 12]. These treatment modalities are invasive, while studies
evaluating long-term efficacy of these methods on flaps are
lacking. Reliable conservative therapy with long-term stable
result is the hiatus in current clinical practice.
Two non-surgical procedures that have been the corner-
stone in treatment for hypertrophic and keloid scars for many
years are pressure garment therapy and therapy with silicones
[13–16].
We hypothesize that combination therapy of silicones
and pressure could lead to reducing edema and rigidity
as well as cause flattening of the facial flap, as an effect
of applying mechanical pressure. Additionally, combina-
tion therapy could have scar enhancing and maturation
accelerating properties, as effects of both silicones and
pressure. In this way, silicone and pressure therapy
could act in synergetic fashion to improve esthetic out-
come of thickened facial flaps with unsatisfying scars.
In order to incorporate pressure and silicone therapy,
we believe that a specialized pressure mask with a sili-
cone layer as inner lining can improve pliability and color
and reduce thickness, edema, and irregularities of flaps
exposing these qualities. In this study, the efficacy of a
unique transparent face mask containing silicone sheets
on the esthetic outcome of postsurgical facial flaps is
assessed.
Materials and methods
Design
In this retrospective study conducted between July 2012
and September 2015, 21 patients were assigned to facial
pressure mask therapy with silicones after they underwent
flap surgery. Patient characteristics and follow-up infor-
mation can be seen in Table 1.
In order to improve the facial skin functionally and
esthetically at the autologous transplantation site (the flap)
after surgery, treatment with a transparent polycarbonate
facial pressure mask with a silicone layer as inner lining
was applied. The different types of surgical flaps used and
the reason for surgery are documented in Tables 2 and 3,
respectively.
Patients
Eligible patients were men or women who had received
facial flap surgery. Only patients in whom the flap clearly
protruded from the normal skin, even after thinning of the
flap, were included. Only patients that did not receive any
prior therapy for their facial flap were included. If these
patients were physically and mentally able and motivated
to wear a polycarbonate facial pressure mask for at least
12 h a day, they were suitable and assigned for facial
mask therapy. Therapy started when the operated skin
passed into the maturation phase of wound healing.
Therefore, therapy started between 1 and 3 months after
flap surgery took place. The study conformed to good
clinical practice guidelines and followed the recommen-
dations of the Declaration of Helsinki. The protocol was
approved by the local ethics committee.
Table 1 Patient
characteristics Age at start therapy (years)
<40 2
40–49 3
50–59 5
>60 11
Mean age (years) 57
Min 34
Max 80
Gender
Male 9
Female 12
Follow-up time (weeks)
10–20 5
20–40 6
40–60 3
60–80 3
80–100 3
>100 1
Mean duration of treatment
(weeks)
46
Min 11
Max 112
Table 2 Surgical flaps
used No.
Abbe flap 1
Bilobed flap 3
Forehead flap 7
Glabella flap 2
Limberg flap 1
Transposition flap 3
Rotation flap 1
Z-plasty 3
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Procedures
From July 2012 to September 2015, 21 patients were assigned
to therapy with a transparent polycarbonate facial mask with a
silicone layer inside. The mask was fully custom fabricated by
an experienced prosthetist.
In order to apply the required pressure to the flap under-
neath the mask, Velcro straps were attached to the polycarbon-
ate outside of the mask. Targeted pressure was 20 mmHg.
Pressure under the mask was measured by means of an aerial
pressure sensor and pump.
Patients were advised and insisted to wear the mask
as long as they possibly could endure, with the objec-
tive to wear the mask at least 12 h every day. When an
adequate and satisfying esthetic result was reached, pa-
tient and doctor mutually decided to stop therapy.
Compliance was evaluated, and if patients were incom-
pliant, mask therapy was stopped. Therapy was also
stopped if patients reported a high level of discomfort.
All included patients of the current study completed the
therapy. The mean duration of the therapy was 46 (11–
112) weeks. During this period, patients returned for
follow-up every 3 to 4 months at the outpatient clinic.
The flaps were assessed at the scar clinic by a team of
experts in scar treatment and management including a
senior plastic surgeon, a resident plastic surgeon, a pros-
thetist, and a physiotherapist. At each visit, POSAS
forms were filled out, and photographs were taken.
Facial mask pressure was monitored on each visit, and
when necessary, adjustments of the mask were per-
formed by the prosthetist.
Assessment of flap
Because no objective and validated tool for assessment
of thickened facial flaps exists, we used the previously
validated Patient and Observer Scar Assessment Scale
(POSAS) for evaluating facial skin and scars at the
transposition site [17]. At most 2 weeks prior to fabri-
cation of the mask, the facial skin and scars were first
assessed. The flap was rated numerically on a 10-step
scale by both the patient and doctor on six items. The
Observer Scale rates vascularity, pigmentation, thick-
ness, relief, pliability, and surface area. The Patient
Scale consists of pain, itchiness, color, pliability, thick-
ness, and relief. Patients were informed to assess the
facial reconstruction as a whole (both flap and scar to-
gether) not solely the scar, on the six components of the
Patient Scale.
One of the reasons POSAS was chosen for flap evaluation
is because it is the only scar assessment tool to include a
component for patients to fill out. Furthermore, we chose
POSAS because of its distinctive feature of reflecting subjec-
tive symptoms like pain and itchiness and because of its use-
fulness for everyday practice [18–20].
On each visit, an expert and the patient independent-
ly filled in a POSAS form in order to assess the trans-
position site.
Data analysis
POSAS scores are presented as means with standard
deviations. Those scores were compared with the use
of one-way ANOVA for significance in means. Two-
tailed values of P < 0.05 were accepted as statistically
significant. All analyses were performed using the sta-
tistical software program SPSS 22.0.
Results
Outcome mean patient, observer, and total POSAS score
All flap sites were evaluated prior to or on the day the mask
therapy started by means of POSAS scores. POSAS scores at
baseline and at the end of therapy were compared by means of
one-way ANOVA.
Figure 1 and Table 4 show that mean POSAS scores de-
creased significantly (P < 0.05) between baseline and end of
therapy, with a total of 18.72 points.
Patient scores also decreased significantly (P < 0.05)
with a mean total of 14.81 points, between baseline and
end of therapy (Table 5).
Observer scores showed a mean reduction of 3.90
points between baseline and end of therapy. However,
this reduction was not statistically significant (Table 6).
Table 3 Reason for flap
surgery No.
Reconstruction of the face after removal of
Basal cell carcinoma 13
Melanoma 2
Radical scar excision 3
Sarcoma 1
Squamous cell carcinoma 2
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Patient compliance
At every follow-up visit, patients were asked how long they
wore the mask. In general, patients declared they wore the
mask for a mean time of 10 to 12 h a day.
Patient scores
Table 5 and Fig. 2 show the six characteristics of the
patient score (pain, itchiness, pigmentation, pliability,
thickness, and relief) at start and end of therapy. All
patient score components showed a decrease after base-
line. The largest decrease was observed in thickness,
with a mean reduction of 3.95 points at the end of
therapy. Itchiness, pigmentation, pliability, thickness,
and relief showed a statistically significant reduction
(P < 0.05) between baseline and end of therapy.
Observer scores
Table 6 and Fig. 3 show the six characteristics of the
observer score (vascularization, pigmentation, thickness,
relief, pliability, and surface area) at start and end of
Table 4 Mean total POSAS scores
Start therapy SD End of therapy SD P value
Total POSAS 48.86 14.97 30.14 9.82 <0.001
Table 5 Mean patient scar scores
Overall patient score
Start therapy SD End of therapy SD P value
Pain 2.48 2.21 1.38 1.32 0.060
Itchiness 3.62 2.42 2.10 1.81 0.026
Pigmentation 5.67 2.99 3.67 1.74 0.012
Pliability 5.90 2.64 2.86 2.01 <0.001
Thickness 6.81 1.81 2.86 2.01 <0.001
Relief 6.67 2.13 3.43 2.04 <0.001
Patient score 31.10 9.76 16.29 7.43 <0.001
Fig. 1 Mean patient, observer,
and total POSAS scores are
shown at baseline and end of
therapy. Statistically significant
differences (P < 0.05) between
means are marked by an asterisk
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therapy. Corresponding to the patient scores, all compo-
nents of the observer score decreased after start of ther-
apy. The largest decrease in observer score was seen in
flap thickness, with a mean reduction of 1.19 points
between baseline and end of therapy. Pliability, thick-
ness, and relief were the observer score components that
showed statistically significant reduction (P < 0.05).
Representative cases are depicted in Figs. 4, 5, 6, 7,
8, 9, 10, and 11.
Discussion
Pressure therapy
Mechanical compression by means of pressure garment ther-
apy is a reputable modality to diminish collagen synthesis by
reducing blood flow. Another hypothesis for the action of
pressure therapy is a decrease in blood flow that causes hyp-
oxia, resulting in fibroblast degeneration and loosening of
collagen fibrils [21, 22]. Pressure garment therapy has also
proven to result in significant improvement in scar erythema
and thickness in postburn hypertrophic scars [23].
Since the 1980s roughly, various types of facial topical
therapies have been described [24, 25]. The transparent face
mask or transparent face orthosis is a well-known and effec-
tive modality in the management of burn-related hypertrophic
scars, as it has proven to reduce hypertrophic scars significant-
ly [26]. For the fabrication process of the mask, different
Table 6 Mean observer scar scores
Overall observer score
Start
therapy
SD End of
therapy
SD P value
Vascularization 3.62 1.88 3.00 1.55 0.252
Pigmentation 2.14 1.42 2.00 1.05 0.713
Thickness 3.38 1.40 2.19 1.08 0.004
Relief 3.48 1.20 2.67 1.16 0.035
Pliability 2.95 1.43 1.90 1.09 0.011
Surface area 2.57 1.63 1.95 0.87 0.132
Observer score 17.76 7.38 13.86 4.99 0.051
Fig. 2 Components of the patient
score as part of the total POSAS
score are displayed at start and
end of therapy. Statistically
significant differences (P < 0.05)
between means are marked by an
asterisk
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techniques exist, among the formation of both manual and
laser-generated molds [24, 27].
When pressure therapy is applied to flaps in extremities, it
reduces edema, and it helps to reconstruct and reshape a defect
after flap surgery [28]. Further evidence for pressure therapy
in reshaping and correcting flaps can mainly be addressed as
anecdotal.
Silicone therapy
Silicone therapy for scars has become standard practice
among plastic surgeons, as there is good clinical evidence of
the efficacy [29, 30]. One of the mechanisms to occur after
application of silicones to the skin is an increase of hydration.
As an effect of increased hydration, capillary activity could
decrease, thereby reducing local collagen deposition [31]. The
clinical effects of increased hydration include improvement of
pruritus, pain, pliability, and decrease of edema [32, 33].
Combination therapy
However, the combined effect of pressure therapy and sili-
cones is less studied. A randomized controlled trial (RCT)
demonstrated that silicones combined with pressure therapy
were associated with significant improvement in pliability,
thickness, and vascularity of 38 hypertrophic burn scars
[34]. A smaller pilot RCT showed inconclusive evidence on
the potential beneficial effect of combination therapy on 30
hypertrophic burn scars [35]. A larger RCT demonstrated
combined therapy to be effective in improving thickness of
hypertrophic postburn scars, compared to silicone and pres-
sure therapy separately [36].
Fig. 3 Components of the
observer score as part of the total
POSAS score are displayed at
start and end of therapy.
Statistically significant
differences (P < 0.05) between
means are marked by an asterisk
Fig. 4 A 50-year old female patient at the start of pressure mask therapy
4 months after surgery
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In this study, we have shown that specialized facial mask
therapy significantly improves esthetic outcome after facial
flap surgery. Mean total POSAS scores showed a significant
decrease between baseline and end of therapy (Table 4,
Fig. 1), with mean therapy duration of 46 weeks (Table 1).
Our results show patients’ opinion about their facial recon-
struction improved the most, with a significant improvement
(P < 0.05) in itchiness, pliability, pigmentation, thickness, and
relief (Table 5, Fig. 2).
Overall, observer POSAS scores did not show signif-
icant reduction over time (P = 0.051). However, thick-
ness, relief, and pliability, as part of the observer score,
did reduce significantly (Table 6).
To our knowledge, extensive and long-term studies about
esthetic outcome after facial flap surgery are lacking. Also, the
effect of a facial pressure mask for improvement in esthetic
outcome for flaps has not been documented earlier. A limited
amount of methods for esthetic refinement after flap surgery is
available in current clinical practice. Yet, intraoperative intra-
dermal injections of methylprednisolone can reduce flap ede-
ma, according to an animal study [37]. Other methods for
esthetic refinements after facial flap surgery include
photothermolysis and laser resurfacing.
In accordance with our results, we believe that our
specialized pressure mask could be an effective modal-
ity to avoid surgical debulking or thinning of flaps, with
small risk of complications and adverse effects in con-
trast to surgery.
Strengths and limitations
This is the first clinical cohort study to assess the usefulness of
a facial pressure mask with silicones for enhancement after
facial flap surgery. There were some limitations of this study.
In the absence of a flap assessment scale, the validated and
well-known clinical scar assessment tool POSAS is the only
Fig. 5 Same female patient with pressure mask applied during therapy
Fig. 6 Same female patient at the end of pressure mask therapy 9 months
after surgery
Fig. 7 A 48 year-old male patient at the start of pressure mask therapy 3
months after surgery (frontal view)
Fig. 8 A 48 year-old male patient at the start of pressure mask therapy 3
months after surgery (oblique view)
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instrument for flap assessment used in this study. Other
qualitative methods for judging flaps are lacking in this
study. Preferably, the current study would contain a
larger study population and a control group. However,
the vast majority of patients appear to have good esthet-
ic results after facial flap surgery, causing the remaining
eligible patient group to be of small size. Additionally,
the burden of wearing a pressure mask for at least 12 h
a day should not be underestimated. The strength of this
study is that it shows clearly that patients who wore a
pressure mask had strong esthetical improvement of the
facial reconstruction site.
Further research
In order to assess esthetic outcomes after flap reconstruction,
more extensive and precise, 3D digital flap volume measure-
ments, as well as continuous pressure measurements under-
neath the mask, would be of great value. Ideally, further stud-
ies would contain a control group, considering that
information about the natural course of thickened, hypertro-
phic, and unesthetic facial flaps over time is lacking.
A major goal of this study was the improvement in
overall esthetic outcome: restoration of flap skin close
to normal skin. In this study, patients showed a clinical
significant result in esthetic improvement of facial flaps.
Conclusion
In this study, our aim was to assess the efficacy of a special-
ized facial pressure mask on the esthetic outcome of facial
flaps, since no other study examined the effect of facial pres-
sure therapy with silicones on flap enhancement over a rea-
sonable amount of time. Our retrospective study showed that a
transparent facial pressure mask with silicones results in no-
ticeable flap improvement with a long-lasting result, particu-
larly in our patients’ view.
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